2013
DOI: 10.17169/refubium-7150
|View full text |Cite
|
Sign up to set email alerts
|

Der α2C-Adrenozeptor als Zielstruktur für Arzneistoffe zur Behandlung des Raynaud-Phänomens, von Lungenödemen und der Schizophrenie

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles